Home » Medical Devices » Malaysia Peripheral Vascular Devices Market

Malaysia Peripheral Vascular Devices Market By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Guidewires, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $2699

Published: | Report ID: 69180 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Malaysia Peripheral Vascular Devices Market Size 2023  USD 21.87 Million
Malaysia Peripheral Vascular Devices Market, CAGR  6.60%
Malaysia Peripheral Vascular Devices Market Size 2032  USD 36.47 Million

Market Overview

The Malaysia Peripheral Vascular Devices Market is projected to grow from USD 21.87 million in 2023 to USD 36.47 million by 2032, with a compound annual growth rate (CAGR) of 6.60%.

The Malaysia Peripheral Vascular Devices market is driven by the rising prevalence of cardiovascular diseases, which has increased the demand for effective vascular interventions. Additionally, the growing aging population and improving healthcare infrastructure are contributing to market growth. Technological advancements in vascular devices, including minimally invasive procedures and enhanced device accuracy, are boosting adoption rates among healthcare providers. The increasing awareness of early diagnosis and treatment options, alongside rising healthcare expenditure, is further propelling market expansion. Moreover, government initiatives aimed at improving healthcare access and the growing trend towards outpatient treatments are positively influencing the market. These factors, combined with the focus on patient-centric solutions and advancements in medical device manufacturing, are shaping the future of Malaysia’s Peripheral Vascular Devices market.

The Malaysia Peripheral Vascular Devices market exhibits strong regional growth, with key demand concentrated in urban areas such as the Central and Southern regions. These areas benefit from advanced healthcare infrastructure and increasing patient awareness. In contrast, regions like East Malaysia and the East Coast are seeing rising adoption due to improving healthcare access. Key players in the market include global medical device companies such as Terumo Corporation, Medtronic plc, Boston Scientific Corporation, and Abbott Laboratories, which offer a broad range of peripheral vascular devices, including angioplasty balloons, stents, and catheters. Local companies, along with multinational firms, are expanding their presence to cater to growing demand across the country. These key players are focusing on technological innovations, patient-centric solutions, and improving accessibility, contributing to the market’s expansion and the availability of advanced vascular treatments.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The Malaysia Peripheral Vascular Devices market is projected to grow from USD 21.87 million in 2023 to USD 36.47 million by 2032, with a CAGR of 6.60%.
  • Rising prevalence of cardiovascular diseases is a significant market driver, increasing the demand for vascular interventions.
  • Technological advancements in minimally invasive procedures and devices are shaping the market’s growth.
  • The adoption of advanced imaging technologies, such as intravascular ultrasound, is enhancing the effectiveness of peripheral vascular treatments.
  • High device costs and regulatory hurdles are key restraints that could limit market expansion.
  • The Central region leads the market, followed by Southern Peninsula, driven by urbanization and healthcare infrastructure improvements.
  • Key players such as Terumo Corporation, Medtronic, and Boston Scientific are focusing on innovation and expanding their market presence in Malaysia.

Market Drivers

Rising Prevalence of Cardiovascular Diseases

One of the primary drivers of the Malaysia Peripheral Vascular Devices market is the increasing prevalence of cardiovascular diseases (CVDs). As the incidence of conditions like peripheral artery disease (PAD) and chronic venous insufficiency (CVI) rises, the demand for peripheral vascular interventions escalates. CVDs remain one of the leading causes of morbidity and mortality in Malaysia, prompting healthcare professionals to adopt advanced vascular devices for effective treatment and management. For instance, the National Health and Morbidity Survey 2019 reported that 3 in 10 adults in Malaysia have hypertension, and 1 in 5 have diabetes mellitus. This growing health burden creates a significant market opportunity for peripheral vascular devices.

Technological Advancements in Medical Devices

Technological innovation plays a critical role in the growth of the Malaysia Peripheral Vascular Devices market. Recent advancements in medical devices, including the development of minimally invasive procedures, have enhanced the efficiency and outcomes of peripheral vascular interventions. These innovations have made procedures less painful, reduced recovery time, and minimized the risk of complications. For instance, Malaysia has become a preferred hub for over 200 medical device manufacturers, contributing significantly to the country’s economy. As a result, both patients and healthcare providers are increasingly opting for advanced vascular devices, further driving the market.

Aging Population and Healthcare Access

Malaysia’s aging population is another key factor driving the demand for peripheral vascular devices. As the number of elderly individuals increases, so does the risk of developing vascular-related diseases. The elderly are more susceptible to conditions such as arteriosclerosis and varicose veins, which require medical intervention. In response to this demographic shift, the healthcare system is focusing on providing accessible treatment solutions, including the use of advanced vascular devices. Additionally, improvements in healthcare access, both in urban and rural areas, are increasing the adoption of these devices.

Government Initiatives and Healthcare Investment

Government initiatives aimed at enhancing healthcare infrastructure and expanding access to treatment are contributing to the growth of the peripheral vascular devices market in Malaysia. Increased investment in healthcare, particularly in diagnostic tools and treatments, is enabling better management of vascular diseases. Additionally, public health programs that focus on early detection and prevention are raising awareness of vascular conditions, further encouraging the adoption of advanced vascular devices. These initiatives are crucial in fostering a favorable market environment.

Market Trends

Shift Towards Minimally Invasive Procedures

A significant trend in the Malaysia Peripheral Vascular Devices market is the growing preference for minimally invasive procedures. These procedures, which involve smaller incisions and faster recovery times, are becoming increasingly popular among both healthcare providers and patients. Minimally invasive vascular interventions, such as angioplasty and stent placements, are gaining traction due to their ability to reduce surgical risks and hospital stays. For instance, the 2019 Malaysia Surgical Procedure Volumes Database reported a significant increase in the number of minimally invasive procedures performed annually. This shift towards less invasive treatments is driving the demand for advanced peripheral vascular devices, as they are critical in ensuring the success of such procedures.

Adoption of Advanced Imaging and Diagnostic Technologies

The adoption of advanced imaging and diagnostic technologies is another key trend shaping the Malaysia Peripheral Vascular Devices market. Devices that offer real-time, high-resolution imaging, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are increasingly being used to guide vascular interventions. These technologies help healthcare providers make more accurate diagnoses and treatment decisions, leading to better patient outcomes. For instance, the Malaysia Diagnostic Imaging Market report highlights the growing use of advanced imaging modalities like MRI and CT scans in vascular procedures. The integration of these diagnostic tools with peripheral vascular devices is expected to continue to grow, improving the effectiveness of vascular procedures.

Focus on Patient-Centric Solutions

As patient outcomes become a central focus in the healthcare sector, there is a growing trend towards patient-centric solutions in the peripheral vascular devices market. This includes the development of devices that are not only more effective but also designed with patient comfort in mind. Manufacturers are focusing on creating devices that minimize discomfort, reduce recovery times, and offer improved long-term outcomes. For instance, Malaysia’s healthcare system is undergoing a transformative shift towards more patient-centric care, as emphasized by the Health Minister. This patient-centric approach is driving innovation in the market, encouraging the development of devices that cater to the specific needs and preferences of individuals undergoing vascular treatments.

Expanding Role of Digital Health and Telemedicine

The integration of digital health solutions and telemedicine is also transforming the landscape of the Malaysia Peripheral Vascular Devices market. Remote monitoring and teleconsultation technologies are increasingly being used to manage patients with peripheral vascular diseases, enabling continuous care and reducing the need for frequent hospital visits. Digital health tools are improving patient engagement and adherence to treatment plans, which, in turn, supports the adoption of peripheral vascular devices. As telemedicine continues to evolve, it is expected to play a pivotal role in the management and treatment of vascular diseases in Malaysia.

Market Challenges Analysis

High Cost of Advanced Devices

One of the primary challenges faced by the Malaysia Peripheral Vascular Devices market is the high cost associated with advanced medical devices. Peripheral vascular devices, particularly those used in minimally invasive procedures, can be expensive, making them less accessible for certain patient populations. Hospitals and healthcare providers, especially those in smaller or rural areas, may face budgetary constraints that limit their ability to adopt the latest technologies. Additionally, high device costs may result in higher treatment expenses, placing a financial burden on patients and healthcare systems. This challenge necessitates the need for more cost-effective solutions without compromising quality and outcomes.

Regulatory and Approval Hurdles

Another significant challenge in the market is the complex regulatory landscape governing the approval and commercialization of peripheral vascular devices in Malaysia. Regulatory requirements can delay the introduction of new devices, as manufacturers must navigate a stringent approval process before products can be marketed and sold. For instance, the Medical Device Authority (MDA) in Malaysia requires all medical devices to undergo a thorough registration process, which can be time-consuming and costly. Furthermore, ensuring compliance with local regulations and meeting the safety standards required for approval adds to the time and cost involved in bringing devices to market. These regulatory hurdles may slow innovation and hinder the rapid adoption of cutting-edge vascular technologies, limiting the potential for market growth.

Market Opportunities

Expanding Healthcare Infrastructure

One of the key opportunities in the Malaysia Peripheral Vascular Devices market lies in the country’s expanding healthcare infrastructure. With continued investments in both public and private healthcare sectors, there is a growing demand for advanced medical devices, including those used for peripheral vascular interventions. The government’s focus on improving healthcare access, particularly in underserved regions, presents a significant opportunity for manufacturers to introduce innovative vascular devices that address the needs of a broader patient base. As healthcare facilities enhance their capabilities to treat vascular diseases, the demand for high-quality, efficient peripheral vascular devices is expected to rise, creating opportunities for growth and market penetration.

Increasing Focus on Preventive Care and Early Detection

Another promising opportunity for the Malaysia Peripheral Vascular Devices market is the rising emphasis on preventive care and early detection of vascular diseases. As awareness about the importance of early intervention grows, more individuals are seeking diagnostic services and treatments for conditions like peripheral artery disease (PAD) and varicose veins. This trend, supported by government health initiatives and educational campaigns, is increasing the need for advanced diagnostic and treatment devices. Peripheral vascular devices that offer precise, effective solutions for early diagnosis and intervention are positioned to capture a larger share of the market. Additionally, as patient outcomes become a higher priority in healthcare systems, there is an opportunity for manufacturers to develop devices that not only address vascular conditions but also enhance the overall quality of care.

Market Segmentation Analysis:

By Type:

The Malaysia Peripheral Vascular Devices market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, angioplasty balloons and stents are leading the market due to their widespread use in treating peripheral artery disease (PAD) and other vascular conditions. Angioplasty balloons are used to widen narrowed or blocked blood vessels, while stents help maintain vessel patency. Catheters and guidewires are essential for facilitating minimally invasive procedures, ensuring smooth navigation through blood vessels during treatments. These devices are integral to modern vascular interventions, contributing to improved patient outcomes and reduced recovery times. The “others” segment includes various additional devices, such as vascular access devices and diagnostic tools, which are also gaining traction as advancements in technology improve treatment efficacy. As the market grows, the demand for advanced, high-quality devices continues to rise, driven by the increasing prevalence of vascular diseases in Malaysia.

By End-user:

The end-user segment of the Malaysia Peripheral Vascular Devices market includes hospitals, ambulatory surgical centers, and specialty clinics. Hospitals remain the largest end-user due to their capacity to handle complex vascular interventions and their advanced infrastructure. However, ambulatory surgical centers are rapidly growing in prominence, driven by the increasing preference for outpatient procedures that reduce hospital stays and overall treatment costs. These centers offer a more efficient, patient-friendly approach to vascular care. Specialty clinics, focusing on vascular conditions, are also contributing to market growth as they provide specialized care and attract patients seeking targeted treatments for conditions like PAD. As healthcare providers increasingly prioritize convenience and cost-effective care options, the demand for peripheral vascular devices is likely to continue expanding across these end-user segments.

Segments:

Based on Type:

  • Angioplasty Balloons
  • Angioplasty Stents
  • Catheters
  • Guidewires
  • Others

Based on End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Based on the Geography:

  • Northern Peninsula
  • Southern Peninsula
  • Central
  • East Coast
  • East Malaysia

Regional Analysis

Central Region

The Central region, encompassing Kuala Lumpur and Selangor, dominates the Malaysia Peripheral Vascular Devices market with the highest market share, estimated at around 40%. This area benefits from the presence of advanced healthcare facilities, including major hospitals and specialized clinics, which offer comprehensive diagnostic and treatment options for vascular diseases. The high concentration of healthcare professionals and the availability of state-of-the-art medical technologies also contribute to the region’s significant share. Furthermore, the Central region attracts a large patient base due to its urban population, increasing the demand for advanced peripheral vascular devices such as angioplasty balloons, stents, and guidewires. As the healthcare system in this region continues to improve, the demand for vascular devices is expected to grow further.

Southern Peninsula

The Southern Peninsula, which includes regions like Johor, holds a market share of approximately 25% in the Malaysia Peripheral Vascular Devices market. This region’s growth is largely attributed to its proximity to Singapore, which influences healthcare standards and market trends. The increasing urbanization in cities such as Johor Bahru is driving demand for more advanced healthcare services, leading to a rise in peripheral vascular interventions. Hospitals and ambulatory surgical centers in the region are expanding their capabilities to offer minimally invasive procedures, which further supports the adoption of peripheral vascular devices. As healthcare investments continue to flow into the Southern Peninsula, the region’s market share is expected to continue its upward trajectory.

Northern Peninsula, East Coast, and East Malaysia

The Northern Peninsula, including states like Penang, holds about 15% of the market share, with continued growth anticipated due to increasing awareness of vascular health and the gradual expansion of healthcare facilities. The East Coast region, covering states such as Kelantan and Terengganu, holds around 10% of the market share, benefiting from improving healthcare access and government-led initiatives aimed at enhancing medical services in rural areas. Meanwhile, East Malaysia, which includes Sabah and Sarawak, has a smaller market share of approximately 10%, but it shows significant growth potential. As healthcare infrastructure improves in these regions and awareness of peripheral vascular conditions increases, demand for vascular devices is expected to grow, contributing to the broader expansion of the market across Malaysia.

Key Player Analysis

  • Terumo Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Nipro Corporation
  • Cook Medical
  • Asahi Intecc Co., Ltd.
  • Braun Melsungen AG
  • MicroPort Scientific Corporation
  • Cardinal Health

Competitive Analysis

The Malaysia Peripheral Vascular Devices market is highly competitive, with several leading players driving innovation and expanding their market presence. Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Nipro Corporation, Cook Medical, Asahi Intecc Co., Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, and Cardinal Health are the key companies dominating the market. Companies are increasingly investing in research and development to introduce advanced, minimally invasive devices that improve patient outcomes and reduce recovery times. These innovations, particularly in angioplasty balloons, stents, catheters, and guidewires, are driving the growth of the market. In addition to product innovation, manufacturers are focusing on expanding their distribution networks and forming strategic partnerships to enhance their market presence across the country. The market is also influenced by the growing demand for patient-centric solutions, with many players focusing on devices that are not only effective but also easy to use and cost-efficient. However, the competitive environment remains challenging due to high manufacturing costs, regulatory compliance requirements, and price sensitivity in certain market segments. To stay ahead, companies are also adopting advanced technologies, such as real-time imaging and diagnostic tools, to support the effectiveness of vascular procedures. For instance, the integration of intravascular ultrasound (IVUS) and optical coherence tomography (OCT) in vascular interventions has significantly improved diagnostic accuracy and treatment outcomes. As a result, the market remains dynamic, with new entrants and existing players continually vying for a share in the growing demand for peripheral vascular devices in Malaysia.

Recent Developments

  • In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
  • In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD’s ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
  • In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
  • In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The market concentration of Malaysia Peripheral Vascular Devices is moderate, with a mix of both global and regional players contributing to its growth. While a few large multinational corporations dominate the market, there is a steady presence of local companies that cater to specific regional demands and healthcare needs. These multinational players typically offer a wide range of advanced devices, including angioplasty balloons, stents, catheters, and guidewires, backed by strong research and development capabilities. On the other hand, regional players are focusing on localized innovations and cost-effective solutions to cater to the Malaysian healthcare market. The market is characterized by high product innovation, with continuous advancements in minimally invasive technologies and devices that improve treatment outcomes and patient recovery times. Another significant feature of the market is the increasing adoption of patient-centric devices, such as those with ease of use and enhanced functionality. The growing focus on improving healthcare access in both urban and rural areas has spurred demand for peripheral vascular devices, with hospitals, ambulatory surgical centers, and specialty clinics driving the adoption. Despite the strong competition and technological advancements, the market remains highly regulated, with stringent approval processes that ensure device safety and effectiveness. This balance between competition and regulatory control shapes the overall market dynamics in Malaysia.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The Malaysia Peripheral Vascular Devices market is expected to witness steady growth driven by the increasing prevalence of cardiovascular diseases.
  2. Technological advancements in minimally invasive procedures will continue to enhance device effectiveness and patient outcomes.
  3. The demand for patient-centric devices with improved ease of use and recovery times will rise in the coming years.
  4. Hospitals and ambulatory surgical centers will remain key contributors to the growing adoption of vascular devices.
  5. The expansion of healthcare infrastructure in underserved regions will create new opportunities for market players.
  6. Companies will increasingly focus on cost-effective solutions to cater to the price-sensitive segment of the market.
  7. Strategic partnerships and collaborations will drive market expansion and innovation in vascular technologies.
  8. The regulatory landscape will continue to evolve, with a focus on ensuring device safety and quality.
  9. Growing awareness about vascular health will lead to higher patient demand for preventive care and early intervention.
  10. The market is likely to see more local manufacturers entering the space to meet regional demands and reduce costs.

CHAPTER NO. 1 : INTRODUCTION 19
1.1.1. Report Description 19
Purpose of the Report 19
USP & Key Offerings 19
1.1.2. Key Benefits for Stakeholders 19
1.1.3. Target Audience 20
1.1.4. Report Scope 20
CHAPTER NO. 2 : EXECUTIVE SUMMARY 21
2.1. Peripheral Vascular Devices Market Snapshot 21
2.1.1. Malaysia Peripheral Vascular Devices Market, 2018 – 2032 (USD Million) 22
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23
3.1. Russia-Ukraine and Israel-Palestine War Impacts 23
CHAPTER NO. 4 : PERIPHERAL VASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 24
4.1. Introduction 24
4.2. Market Drivers 25
4.2.1. Increasing prevalence of peripheral artery disease and other vascular conditions 25
4.2.2. Technological advancements in minimally invasive procedures 26
4.3. Market Restraints 27
4.3.1. High cost of peripheral vascular devices and associated procedures 27
4.4. Market Opportunities 28
4.4.1. Growing demand for peripheral vascular devices in emerging economies 28
4.5. Porter’s Five Forces Analysis 29
4.6. Buying Criteria 30
CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31
5.1. Import Analysis by Malaysia 31
5.1.1. Malaysia Peripheral Vascular Devices Market Import Volume/Revenue, By Malaysia, 2018 – 2023 31
5.2. Export Analysis by Malaysia 32
5.2.1. Malaysia Peripheral Vascular Devices Market Export Volume/Revenue, By Malaysia, 2018 – 2023 32
CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33
6.1. Demand Analysis by Malaysia 33
6.1.1. Malaysia Peripheral Vascular Devices Market Demand Volume/Revenue, By Malaysia, 2018 – 2023 33
6.2. Supply Analysis by Malaysia 34
6.2.1. Malaysia Peripheral Vascular Devices Market Supply Volume/Revenue, By Malaysia, 2018 – 2023 34
CHAPTER NO. 7 : PRODUCTION ANALYSIS 35
7.1. Production Analysis by Malaysia 35
7.1.1. Malaysia Peripheral Vascular Devices Market Production Volume/Revenue, By Malaysia, 2018 – 2023 35
CHAPTER NO. 8 : PRICE ANALYSIS 36
8.1. Price Analysis by Type 36
8.1.1. Malaysia Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36
8.1.2. Malaysia Type Market Price, By Type, 2018 – 2023 36
CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37
9.1. Key Raw Materials and Suppliers 37
9.2. Key Raw Materials Price Trend 37
CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38
10.1. Manufacturing Cost Analysis 38
10.2. Manufacturing Process 38
CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39
11.1. Company Market Share Analysis – 2023 39
11.2. Value Chain Analysis 39
11.2.1. Malaysia Peripheral Vascular Devices Market: Company Market Share, by Volume, 2023 40
11.2.2. Malaysia Peripheral Vascular Devices Market: Company Market Share, by Revenue, 2023 41
11.2.3. Malaysia Peripheral Vascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 41
11.2.4. Malaysia Peripheral Vascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 42
11.3. Malaysia Peripheral Vascular Devices Market Company Volume Market Share, 2023 43
11.4. Malaysia Peripheral Vascular Devices Market Company Revenue Market Share, 2023 44
11.5. Company Assessment Metrics, 2023 44
11.5.1. Stars 44
11.5.2. Emerging Leaders 44
11.5.3. Pervasive Players 44
11.5.4. Participants 44
11.6. Start-ups /SMEs Assessment Metrics, 2023 44
11.6.1. Progressive Companies 44
11.6.2. Responsive Companies 45
11.6.3. Dynamic Companies 45
11.6.4. Starting Blocks 45
11.7. Strategic Developments 46
11.7.1. Acquisitions & Mergers 46
New Product Launch 46
Malaysia Expansion 46
11.8. Key Players Product Matrix 47
CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48
12.1. PESTEL 48
12.1.1. Political Factors 48
12.1.2. Economic Factors 48
12.1.3. Social Factors 48
12.1.4. Technological Factors 48
12.1.5. Environmental Factors 48
12.1.6. Legal Factors 48
12.2. Adjacent Market Analysis 48
CHAPTER NO. 13 : PERIPHERAL VASCULAR DEVICES MARKET – BY TYPE SEGMENT ANALYSIS 49
13.1. Peripheral Vascular Devices Market Overview, by Type Segment 49
13.1.1. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50
13.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By Type 51
13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51
13.1.4. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52
13.2. Angioplasty Balloons 53
13.3. Angioplasty Stents 54
13.4. Catheters 55
13.5. Guidewires 56
13.6. Others 57
CHAPTER NO. 14 : PERIPHERAL VASCULAR DEVICES MARKET – BY END-USER SEGMENT ANALYSIS 58
14.1. Peripheral Vascular Devices Market Overview, by End-user Segment 58
14.1.1. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59
14.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By End-user 60
14.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 60
14.1.4. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61
14.2. Hospitals 62
14.3. Ambulatory Surgical Centers 63
14.4. Specialty Clinics 64
CHAPTER NO. 15 : PERIPHERAL VASCULAR DEVICES MARKET – MALAYSIA ANALYSIS 65
15.1. Type 65
15.1.1. Malaysia Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65
15.2. Malaysia Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65
15.3. End-user 66
15.3.1. Malaysia Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66
15.3.2. Malaysia Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66
CHAPTER NO. 16 : COMPANY PROFILES 67
16.1. Terumo Corporation 67
16.1.1. Company Overview 67
16.1.2. Product Portfolio 67
16.1.3. Swot Analysis 67
16.1.4. Business Strategy 68
16.1.5. Financial Overview 68
16.2. Medtronic plc 69
16.3. Boston Scientific Corporation 69
16.4. Abbott Laboratories 69
16.5. Nipro Corporation 69
16.6. Cook Medical 69
16.7. Asahi Intecc Co., Ltd. 69
16.8. B. Braun Melsungen AG 69
16.9. MicroPort Scientific Corporation 69
16.10. Cardinal Health 69

List of Figures
FIG NO. 1. Malaysia Peripheral Vascular Devices Market Revenue, 2018 – 2032 (USD Million) 22
FIG NO. 2. Porter’s Five Forces Analysis for Malaysia Peripheral Vascular Devices Market 29
FIG NO. 3. Malaysia Peripheral Vascular Devices Market Import Volume/Revenue, By Malaysia, 2018 – 2023 31
FIG NO. 4. Malaysia Peripheral Vascular Devices Market Export Volume/Revenue, By Malaysia, 2018 – 2023 32
FIG NO. 5. Malaysia Peripheral Vascular Devices Market Demand Volume/Revenue, By Malaysia, 2018 – 2023 33
FIG NO. 6. Malaysia Peripheral Vascular Devices Market Supply Volume/Revenue, By Malaysia, 2018 – 2023 34
FIG NO. 7. Malaysia Peripheral Vascular Devices Market Production Volume/Revenue, By Malaysia, 2018 – 2023 35
FIG NO. 8. Malaysia Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36
FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37
FIG NO. 10. Manufacturing Cost Analysis 38
FIG NO. 11. Manufacturing Process 38
FIG NO. 12. Value Chain Analysis for Malaysia Peripheral Vascular Devices Market 39
FIG NO. 13. Company Share Analysis, 2023 40
FIG NO. 14. Company Share Analysis, 2023 41
FIG NO. 15. Company Share Analysis, 2023 41
FIG NO. 16. Company Share Analysis, 2023 42
FIG NO. 17. Peripheral Vascular Devices Market – Company Volume Market Share, 2023 43
FIG NO. 18. Peripheral Vascular Devices Market – Company Revenue Market Share, 2023 44
FIG NO. 19. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50
FIG NO. 20. Market Attractiveness Analysis, By Type 51
FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51
FIG NO. 22. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52
FIG NO. 23. Malaysia Peripheral Vascular Devices Market for Angioplasty Balloons, Revenue (USD Million) 2018 – 2032 53
FIG NO. 24. Malaysia Peripheral Vascular Devices Market for Angioplasty Stents, Revenue (USD Million) 2018 – 2032 54
FIG NO. 25. Malaysia Peripheral Vascular Devices Market for Catheters, Revenue (USD Million) 2018 – 2032 55
FIG NO. 26. Malaysia Peripheral Vascular Devices Market for Guidewires, Revenue (USD Million) 2018 – 2032 56
FIG NO. 27. Malaysia Peripheral Vascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 57
FIG NO. 28. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59
FIG NO. 29. Market Attractiveness Analysis, By End-user 60
FIG NO. 30. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 60
FIG NO. 31. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61
FIG NO. 32. Malaysia Peripheral Vascular Devices Market for Hospitals, Revenue (USD Million) 2018 – 2032 62
FIG NO. 33. Malaysia Peripheral Vascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 63
FIG NO. 34. Malaysia Peripheral Vascular Devices Market for Specialty Clinics, Revenue (USD Million) 2018 – 2032 64

List of Tables
TABLE NO. 1. : Malaysia Peripheral Vascular Devices Market: Snapshot 21
TABLE NO. 2. : Drivers for the Peripheral Vascular Devices Market: Impact Analysis 25
TABLE NO. 3. : Restraints for the Peripheral Vascular Devices Market: Impact Analysis 27
TABLE NO. 4. : Malaysia Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 36
TABLE NO. 5. : Key Raw Materials & Suppliers 37
TABLE NO. 6. : Malaysia Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65
TABLE NO. 7. : Malaysia Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65
TABLE NO. 8. : Malaysia Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66
TABLE NO. 9. : Malaysia Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

Frequently Asked Questions:

What is the current size of the Malaysia Peripheral Vascular Devices Market?

The Malaysia Peripheral Vascular Devices Market is valued at USD 21.87 million in 2023 and is projected to grow to USD 36.47 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.60%.

What factors are driving the growth of the Malaysia Peripheral Vascular Devices Market?

Key growth drivers include the rising prevalence of cardiovascular diseases, advancements in minimally invasive procedures and medical technologies, increasing awareness of early diagnosis and treatment options, a growing aging population, and government initiatives to improve healthcare infrastructure and access.

What are the key segments within the Malaysia Peripheral Vascular Devices Market?

The market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. End-user segments include hospitals, ambulatory surgical centers, and specialty clinics. Geographically, the market is divided into Northern Peninsula, Southern Peninsula, Central, East Coast, and East Malaysia regions.

What are some challenges faced by the Malaysia Peripheral Vascular Devices Market?

Challenges include the high cost of advanced peripheral vascular devices, regulatory hurdles delaying device approvals, budgetary constraints in smaller healthcare facilities, and price sensitivity among patients, especially in rural and underdeveloped areas.

Who are the major players in the Malaysia Peripheral Vascular Devices Market?

Key players include Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Nipro Corporation, Cook Medical, Asahi Intecc Co., Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, and Cardinal Health. These companies focus on innovation, strategic partnerships, and regional expansions to drive market growth.

Malaysia Grid Modernization Market

Published:
Report ID: 73777

Malaysia Soldier Modernization Market

Published:
Report ID: 72658

Malaysia Military Aircraft Modernization Market

Published:
Report ID: 71170

Malaysia Medical Gas and Equipment Market

Published:
Report ID: 70304

Malaysia NATO Military Aircraft Modernization Market

Published:
Report ID: 69982

Malaysia Elevator Modernization Market

Published:
Report ID: 68349

Malaysia Biopharmaceuticals Contract Manufacturing Market

Published:
Report ID: 67948

Malaysia Mainframe Modernization Services Market

Published:
Report ID: 66680

Malaysia Managed Services Market

Published:
Report ID: 65623

South Africa Medical Gas and Equipment Market

Published:
Report ID: 75642

Compliance Monitoring Devices Market

Published:
Report ID: 75564

Continuous Glucose Monitoring Devices Market

Published:
Report ID: 4258

Internal Radiation Therapy Market

Published:
Report ID: 75411

Image Guided Radiotherapy Market

Published:
Report ID: 75382

Flat Panel X-Ray Detectors Market

Published:
Report ID: 74896

Hemostasis Testing Systems Market

Published:
Report ID: 74856

Cardiac Ultrasound Systems Market

Published:
Report ID: 74702

Aesthetic Medical Devices Market

Published:
Report ID: 74587

Italy Diabetes Care Devices Market

Published:
Report ID: 64898

Transplant Monitoring Kits Market

Published:
Report ID: 74464

Malignant Pleural Effusion Market

Published:
Report ID: 74366

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$5699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN